Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as BTG plc ( LON:BTG ), with a market cap of UK£2.01b, often get neglected by retail investors.

To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.

Banco BTG Pactual SA, Latin America’s largest independent investment bank, agreed to buy HSBC Holdings Plc’s operations in ...

Boston Scientific Corp. BSX 0.67% has agreed to buy British health-care firm BTG PLC for £3.3 billion ($4.24 billion), bolstering its presence in the growing field of interventional medicine ...

A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to improperly marketing its embolic device LC Bead, and will pay about $36 million to resolve its criminal and civil liability ...

BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company ...

LONDON--Shares in BTG PLC (BTG.LN) fell as much as 11% Tuesday after the company reported lower annual pretax profit and dissapointed analysts on its revenue outlook.

BTG plc: Varisolve NDA submitted to the FDA London, UK, 4 February 2013: BTG plc (LSE: BTG), the specialist healthcare company, today announces that a New Drug Application (NDA) seeking approval of ...

London, UK, 16 July 2013: BTG plc (LSE: BTG), the specialist healthcare company, today announces its interim management statement for the period from 1 April 2013 to 15 July 2013.

Boston Scientific Corp. BSX said Tuesday that it has agreed to a takeover bid for U.K. specialty health-care company BTG PLC (BTG.LN) in a deal worth 3.3 billion pounds ($4.23 billion). The ...

(RTTNews) - BTG plc (BTG.L) reported that the US FDA's Anesthesiology and Respiratory Therapy Devices Panel of the Medical Devices Advisory Committee voted against the approval of the Elevair ...

Shares of BTG PLC (BTG.LN) fell in early trade Friday after the health-care company said that a U.S. Food & Drug Administration panel has voted against the approval of its Elevair Endobronchial ...